This website is part of the ECDC (European Centre for Disease Prevention and Control) network
See entire ECDC network
EPIET
Eurosurveillance
Escaide
European Antibiotic Awareness Day
ECDC Portal
View
pda
web
Font
:
Accessibility
Home
About ESCAIDE
Travel & Accommodation
Programme
Registration
Materials
Presenter’s corner
Foreword
Conference committee
Contact us
Partners
Previous conferences
About the conference
Location
EAN travel grants
Hotel accommodation
Abstracts
EAN Prize
Photos
Posters
Presentations
Webcasts
Archive
Archive by topic
Archive by year
Presentations
Posters
About speakers
Presentations - Influenza
Presentations 2011
Postpandemic Sentinel Surveillance for Severe Acute Respiratory Infections, Romania, 2010-2011, Dr. Odette Nicolae
The burden of influenza: evaluation of the Disability Adjusted Life Years (DALYs) and hospital utilization in Italy, Mrs. Silvia Longhi
Surveillance of Hospitalised Severe Cases of Influenza A(H1N1) 2009 and Related Fatalities during the 2009 Influenza Pandemic in Ten EU Countries, Dr. René Snacken
Influenza vaccine effectiveness in Europe, 2010-11: estimates from the I-MOVE multicentre case-control study by age group, influenza subtype and among target groups for vaccination, Ms. Esther Kissling
Abrupt increase in incidence of narcolepsy in children and adolescents, not in adults after pandemic vaccination in Finland in 2010, Dr. Hanna Nohynek
Presentations 2010
Impact of the pandemic influenza A(H1N1)v vaccination campaign in Jersey, 2009-2010, Ms. Mariana Haeberer
Overview of pandemic (H1N1) 2009 influenza vaccination in Europe. Preliminary results of VENICE survey conducted in 2010, Mrs. Jolita Mereckiene
Factors associated with fatal outcome of 2009 pandemic influenza (H1N1) infections in Germany, Dr. Hendrik Wilking
Clinical and laboratory characteristics of hospitalized patients with influenza A/H1N1 2009 and other acute respiratory infections: A prospective case-control study, Mr. Benedikt Greutélaers
Risk factors and outcome associated with concurrent invasive bacterial infections in laboratory confirmed pandemic (H1N1) 2009 influenza cases in England, 2009- 2010, Ms. Marie-Amelie Degail
Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-10: results of the I-MOVE multicentre case-control study, Dr. Bruno Ciancio
Timely monitoring of excess mortality during the 2009 pandemic: Results from the EURO-MOMO pilot project, Dr. Kåre Mølbak
Surveillance of Influenza-Associated Hospitalisations during the 2009 Influenza Pandemic in Denmark: the Hidden Burden on the Young, Dr. Katarina Widgren
Low influenza A(H1N1)2009 population and high risk group vaccination coverage during the 2009-2010 pandemic in France, Dr. Jean- Paul Guthmann
Estimating Pandemic Influenza Vaccine Effectiveness in the frame of the Spanish Influenza Sentinel Surveillance System, season 2009-2010, Spain, Dr. Camelia Savulescu
Pandemic influenza vaccine effectiveness estimates using the screening method in the frame of Spanish Influenza Surveillance Sentinel System, season 2009-2010, Dr. Amparo Larrauri
The 2009 pandemic influenza A (H1N1) virus: pre-pandemic cross-reactive antibodies in German adults, Ms. Sandra Dudareva
Outbreak of influenza A 2009 H1N1 virus in a Military Spanish semi-closed facility, May 2009, Dr. Mayo Montero
Behavioural risk factors for influenza transmission in households, Dr. Cornelius Remschmidt
Epidemiology of Victoria (Australia)'s first 1,000 pandemic (H1N1) 2009 influenza cases: the role of youth through schools in transmission, Dr. Isabel Bergeri
Impact of media coverage on the surveillance of 2009 pandemic influenza A(H1N1) in Wales, April - December 2009, Ms. Maria Keramarou
Oseltamivir resistant 2009 H1N1 pandemic influenza virus infection in England and Scotland, 2009- 2010, Ms. Laurence Calatayud
Pandemic influenza in Northern Ireland: characteristics of hospitalised patients and risk factors for severe outcomes and death, June 2009 to February 2010, Dr. Otilia Sfetcu
The relative impact of 2009 pandemic influenza A(H1N1) in the general population compared to seasonal influenza in the Netherlands was most marked among 5-14 year olds, Mrs. Rianne van Gageldonk-Lafeber
First results from a household-based study analysing the effectiveness of face masks and hand hygiene to prevent transmission of pandemic (H1N1) 2009 virus, Dr. Thorsten Suess
Timeliness of international contact tracing among flight passengers for Pandemic Influenza A(H1N1) 2009, Mrs. Corien Swaan
The burden of Pandemic Influenza A (H1N1) 2009 disease in Hospitals and ICUs – results from a new hospital Surveillance, Germany 2009/2010, Dr. Cornelia Adlhoch
Attitudes and practice of the Portuguese population towards vaccination against pandemic influenza virus, Mrs. Eleonora Paixão
The Influenzanet self-reporting system warrants consistency in epidemic monitoring across countries and seasons, Sander van Noort, Calouste Gulbenkian Foundation, Portugal
The 2009 influenza A (H1N1)v pandemic in the EU/EEA countries, Dr. Andrew Amato Gauci- ECDC, Sweden
Estimating the mortality & YPLL attributable to influenza to direct public health action, Dr. Kåre Mølbak- Statens Serum Institut, Denmark
How will we do even better next time – how pandemic preparedness and response in Europe should proceed from here on – a personal view
How surveillance in a pandemic should be improved with seroepidemiology, Dr. Pia Hardelid, HPA, UK
Presentations 2009
Assessing the effectiveness of H1N1 vaccine in Europe, Dr Alan Moren, I-Move
Overview of the current situation regarding H1N1 with particular emphasis on vaccine strategies and prioritization, Professor Angus Nicoll, ECDC
Novel A(H1N1)v case and contact management in 13 European countries during the containment phase, April 27 – May 15, 2009, Dr Sandra Cohuet
Outcomes of two case investigations focusing on duration of viral shedding and the contact management among some of the first reported cases of influenza A(H1N1) in Germany, Ms Stine Nielsen
Compliance to and occurrence of self reported adverse events of prophylactic oseltamivir in nursery and primary school children following exposure to influenza A(H1N1)v, Ms Eva van Velsen
I-MOVE, towards monitoring seasonal and pandemic influenza vaccine effectiveness in Europe: pooled analysis of 5 countries case-control studies in the 2008-9 pilot phase, Ms Ester Kissling
Excess Mortality Related to Outbreaks of Influenza, Respiratory Syncytial Virus and Norovirus in Sweden 2004-2007, Dr Mikael Andersson
Successful expansion of influenza surveillance to 53 countries of the WHO Euro Region, Mrs Tamara Meerhof
Influenza - an underestimated cause of fever in Swedish returned travellers, Dr Brigitta Lesko
Understanding the dynamics of seasonal influenza in Italy: an analysis of disease incidence and population susceptibility, Dr Antonella Lunelli
Active case finding for human infection in an H5N1 epizootic area - the first human H5N1 case in Lao PDR, 2007, Mr Phonepaseuth Ounaphom
Can we measure influenza vaccine effectiveness using a simple method? Comparing two study designs using data from the Spanish Influenza Sentinel Surveillance System, 2008-2009, Dr Camelia Savulescu
Can we use web-based medical education to improve mandatory disease reporting in Germany?, Mr Guy Oscar Kamga Wambo
First outbreak of influenza A(H1N1)v without travel history in a school in the Toulouse district, France, June 2009, Dr Anne Guinard
Epidemiology and control of the new influenza A(H1N1)v epidemic in the Netherlands: the first 115 cases, Dr Susan Hahné
Risk factors for infection with novel influenza virus A(H1N1) in a teenage party cohort, Germany, June 2009, Dr Julia Hermes
Assessment of strategies based on the use of a pandemic inactivated vaccine in mitigating influenza A/H1N1 spread: a modeling study, Dr Vana Sypsa
New Influenza A(H1N1) Virus Outbreak in a School, South-East London, April-May 2009, Dr Laurence Calatayud
Share
European Centre for Disease Prevention and Control (ECDC) 2005 - 2012
Legal notice